AbbVie disappoints for the quarter as several promising drugs come up short

This was a letdown from Abbvie because some key products that are expected to drive the company's growth missed the mark.

from US Top News and Analysis https://ift.tt/LIdMvYp
https://ift.tt/Q1a5zUv